Physician profile
Stacy D Webb
NPI 1720367501
$1,447.12
in general payments reported to CMS, 2019-2025
18 companies · $295 in 2025
The $295 reported for 2025 was more than what 84% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $96.66 · 2022: $233 · 2023: $568 · 2024: $255 · 2025: $295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,117.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $439.50 | 2022-2025 | Azstarys |
| Neurelis, INC. | $145.18 | 2023-2024 | Valtoco |
| Supernus Pharmaceuticals, INC. | $128.36 | 2023-2025 | Qelbree, Qelbree |
| Abbvie INC. | $125.00 | 2022 | |
| Ironshore Pharmaceuticals INC. | $117.58 | 2023-2024 | Jornay Pm |
| Sanofi Pasteur INC. | $84.41 | 2021-2025 | |
| Collegium Pharmaceutical, INC. | $69.84 | 2025 | Jornay Pm |
| Tris Pharma INC | $60.96 | 2021-2024 | Dyanavel Xr |
| Itamar Medical INC | $57.45 | 2023 | Watchpatone |
| Merck Sharp & Dohme LLC | $42.34 | 2021-2024 | Vaxelis, Vaqta, Gardasil 9 |
| Organon LLC | $29.38 | 2025 | |
| Ultragenyx Pharmaceutical INC. | $29.12 | 2023 | |
| Pfizer INC. | $27.23 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $24.02 | 2024 | Flumist Quadrivalent |
| Seqirus USA INC | $21.70 | 2024 | Fluad, Flucelvax |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verrica Pharmaceuticals INC. | $17.21 | 2025 | Ycanth |
| Stryker Corporation | $15.31 | 2022 | |
| Glaxosmithkline, LLC. | $12.53 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacy Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.